Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Basic Reset was a private Tennessee health and wellness company that marketed and distributed dietary supplements, CBD products, over-the-counter drug-like products, and at least one medical device from Hendersonville, Tennessee. The company appears to have operated primarily in the consumer wellness and alternative health market rather than as a traditional biotech or pharmaceutical developer. In 2019, the U.S. Department of Justice and FDA announced a consent decree permanently enjoining Basic Reset and related parties from distributing products until they complied with federal requirements, and FDA later announced a recall covering numerous Basic Reset and Biogenyx product lines. Available evidence indicates the Tennessee corporate entity later became inactive/terminated. It does not appear to have a conventional drug-development pipeline or clinical-stage therapeutic programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Basic Reset.